Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Adipose-derived MSCs for Trophic Ulcers
NCT04457037Phase 2Completed
- Start
- Oct 2009
- Primary completion
- Dec 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous adipose-derived mesenchymal stromal cells in trophic ulcer. Primary endpoints: Number of patients with trophic ulcers cured at 1 month and Number of patients with treatment-related adverse events at 4 weeks. Started Oct 2009; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
trophic ulcer
Beyond the preview
Go deeper on NCT04457037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04457037.